BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 3034758)

  • 1. Corticotropin-releasing factor in humans. II. CRF stimulation in patients with diseases of the hypothalamo-pituitary-adrenal axis.
    Müller OA; Stalla GK; von Werder K
    Horm Res; 1987; 25(4):185-98. PubMed ID: 3034758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing factor (CRF): stimulation in normal controls and in patients with Cushing's syndrome.
    Müller OA; Hartwimmer J; Hauer A; Kaliebe T; Schopohl J; Stalla GK; von Werder K
    Psychoneuroendocrinology; 1986; 11(1):49-60. PubMed ID: 3010360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin releasing factor (CRF): diagnostic implications.
    Müller OA; Stalla GK; Hartwimmer J; Schopohl J; von Werder K
    Acta Neurochir (Wien); 1985; 75(1-4):49-59. PubMed ID: 2986422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRH in Cushing's syndrome.
    Müller OA; Stalla GK; von Werder K
    Horm Metab Res Suppl; 1987; 16():51-8. PubMed ID: 2832289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess.
    Colombo P; Passini E; Re T; Faglia G; Ambrosi B
    Clin Endocrinol (Oxf); 1997 Jun; 46(6):661-8. PubMed ID: 9274696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome.
    Chrousos GP; Schulte HM; Oldfield EH; Gold PW; Cutler GB; Loriaux DL
    N Engl J Med; 1984 Mar; 310(10):622-6. PubMed ID: 6319991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRF in the differential diagnosis of Cushing's syndrome: a comparison with the dexamethasone suppression test.
    Grossman AB; Howlett TA; Perry L; Coy DH; Savage MO; Lavender P; Rees LH; Besser GM
    Clin Endocrinol (Oxf); 1988 Aug; 29(2):167-78. PubMed ID: 2854761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticotropin-releasing factor test in normal subjects and patients with hypothalamic-pituitary-adrenal disorders.
    Nakahara M; Shibasaki T; Shizume K; Kiyosawa Y; Odagiri E; Suda T; Yamaguchi H; Tsushima T; Demura H; Maeda T
    J Clin Endocrinol Metab; 1983 Nov; 57(5):963-8. PubMed ID: 6311867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotrophin releasing factor: responses in normal subjects and patients with disorders of the hypothalamus and pituitary.
    Lytras N; Grossman A; Perry L; Tomlin S; Wass JA; Coy DH; Schally AV; Rees LH; Besser GM
    Clin Endocrinol (Oxf); 1984 Jan; 20(1):71-84. PubMed ID: 6319053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin releasing factor: a new tool for the differential diagnosis of Cushing's syndrome.
    Müller OA; Stalla GK; von Werder K
    J Clin Endocrinol Metab; 1983 Jul; 57(1):227-9. PubMed ID: 6304135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of the corticotropin-releasing hormone test to monitor the recovery of patients with Cushing's disease or Cushing's syndrome due to an adrenal adenoma after adenomectomy.
    Hotta MN; Shibasaki T; Suda T; Ling N; Shizume K
    Endocrinol Jpn; 1985 Feb; 32(1):113-25. PubMed ID: 2990881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of hypothalamic-pituitary-adrenal suppression following curative surgery for Cushing's syndrome due to adrenal adenoma.
    Gordon D; Semple CG; Beastall GH; Thomson JA
    Acta Endocrinol (Copenh); 1987 Feb; 114(2):166-70. PubMed ID: 3030034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotropin releasing factor (CRF)-stimulation test in normal controls and patients with disturbances of the hypothalamo-pituitary-adrenal axis.
    Müller OA; Dörr HG; Hagen B; Stalla GK; von Werder K
    Klin Wochenschr; 1982 Dec; 60(24):1485-91. PubMed ID: 6300509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
    Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
    J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
    Gold PW; Kling MA; Khan I; Calabrese JR; Kalogeras K; Post RM; Avgerinos PC; Loriaux DL; Chrousos GP
    Adv Biochem Psychopharmacol; 1987; 43():183-200. PubMed ID: 3035886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing factor (CRF) stimulation test in normal subjects and patients with Cushing's syndrome.
    Zacharieva S; Matrosov P; Stoeva I; Kirilov G
    Exp Clin Endocrinol; 1989 Apr; 93(1):19-28. PubMed ID: 2544435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of synthetic corticotropin-releasing factor in normal individuals and in patients with hypothalamic-pituitary-adrenocortical disorders.
    Jørgensen H; Skare S; Frey H; Hanssen KF; Norman N
    Acta Med Scand; 1985; 218(1):79-84. PubMed ID: 2996312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.